Market Access for Pharmaceutical Products – University of Copenhagen

Master of Medicines Regulatory Affairs > Courses > Market Access for Phar...

Market Access for Pharmaceutical Products – trends and challenges

In the competitive world of pharmaceutical sales, developing a market access strategy and communicating the value of the brands to the ‘payers’ is at the top of the agenda. In recent years, the field of pricing and reimbursement of pharmaceuticals has become more complex and challenging.

Although everyone seems to be talking about market access, very few are able to define it. Who are the new key stakeholders, exactly? Is it no longer the prescribers that decide which drug a patient should use? Is market access only about containing costs for the public budgets or are the benefits for patients and society as well?

Course content

This course will provide insight into the key principles and a practical understanding of ‘market access’ as it relates to the pharmaceutical industry. The course starts with an overview of the key stakeholders and current trends in the global market access of pharmaceuticals followed by a review of the hot topics, challenges and relevant issues through a combination of lectures, discussions, group work, and case studies.

"The course exceeded my expectations and gave me a lot of new ideas to my daily work. Thank you.

Martti Höglund, Market Access Manager, Alcon Nordic A/S

"Interesting topic, well covered by the diverse teachers.

Hans Schambye,  CEO, Galecto Biotech AB

What you will learn

After the course, you will have strengthened your capacity to understand and deal with crucial market access issues. You will have learned about key trends in market access and how market access decisions are made and how the decision frameworks affect requirements for evidence for new health care interventions. You will have acquired:

  • A basic market access vocabulary.
  • Insight into the toolbox of the market access methodologies.
  • An understanding of market access and its relation to the entire pharmaceutical organization. Insight into the key challenges of obtaining market access.
  • Knowledge of the key stakeholders and their influence on the drug reimbursement and prescription process.
  • An understanding of the requirements and different perspectives of payers from key markets and how they are changing.

Course dates

5 days, 20 – 24 August 2018

9:00 – 16:30 at the University of Copenhagen, Frederiksberg Campus, Bülowsvej 17, DK-1870 

Course fee

DKK 19,000.

The fee includes teaching, course materials, and all meals during the course and examination.


The course is for professionals working in the field of pharmaceuticals. It is intended as continuing professional development for professionals in the pharmaceutical industry, particularly in regulatory affairs, medical affairs and sales and marketing, including decision-makers and administrators in the public and private sectors.

The course offers an excellent introduction for those less familiar with market access and will provide a deeper understanding for those with experience within administration and marketing. Please note, however, that the course is not an advanced course for market access specialists.


The course is preapproved as an elective in the Master of Medicines Regulatory Affairs (MRA) programme. The exam is mandatory for master’s students. Read more on the examination. 

NB: Course registration and contact must go through the course description on the Copenhagen Summer University website, as this course is provided under the Copenhagen Summer University concept this year.